Squarepoint Ops LLC Amphastar Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 5,735 shares of AMPH stock, worth $219,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,735

Previous 90,552 93.67%

Holding current value

$219,478

Previous $3.62 Million 92.32%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.99 - $50.09 $3.14 Million - $4.25 Million	-84,817 Reduced 93.67%	5,735 $278,000
Q2 2024 Aug 14, 2024	BUY	$38.65 - $43.48 $328,563 - $369,623	8,501 Added 10.36%	90,552 $3.62 Million
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $59,690 - $88,385	-1,393 Reduced 1.67%	82,051 $3.6 Million
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $614,673 - $869,440	13,816 Added 19.84%	83,444 $5.16 Million
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $2.09 Million - $3.41 Million	58,372 Added 518.59%	69,628 $4 Million
Q1 2023 May 15, 2023	SELL	$27.99 - $37.92 $117,474 - $159,150	-4,197 Reduced 27.16%	11,256 $422,000
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $431,602 - $483,215	15,453 New	15,453 $432,000
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $912,586 - $1.3 Million	-30,634 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $703,356 - $1.12 Million	30,634 New	30,634 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $726,750 - $875,932	-40,760 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.11 - $20.92 $697,403 - $852,699	40,760 New	40,760 $822,000
Q1 2021 May 17, 2021	SELL	$17.21 - $20.65 $184,387 - $221,244	-10,714 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$17.76 - $21.24 $140,676 - $168,242	-7,921 Reduced 42.51%	10,714 $215,000
Q3 2020 Nov 16, 2020	SELL	$17.99 - $22.22 $1.02 Million - $1.26 Million	-56,553 Reduced 75.22%	18,635 $349,000
Q2 2020 Aug 14, 2020	BUY	$14.25 - $22.46 $663,337 - $1.05 Million	46,550 Added 162.55%	75,188 $1.69 Million
Q1 2020 May 15, 2020	SELL	$12.66 - $20.08 $924,192 - $1.47 Million	-73,001 Reduced 71.82%	28,638 $425,000
Q4 2019 Feb 14, 2020	BUY	$17.07 - $20.64 $899,520 - $1.09 Million	52,696 Added 107.67%	101,639 $1.96 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $22.62 $112,425 - $133,005	-5,880 Reduced 10.73%	48,943 $971,000
Q2 2019 Aug 14, 2019	BUY	$18.92 - $22.96 $627,406 - $761,376	33,161 Added 153.08%	54,823 $1.16 Million
Q1 2019 May 15, 2019	SELL	$19.46 - $25.28 $177,280 - $230,300	-9,110 Reduced 29.6%	21,662 $443,000
Q4 2018 Feb 14, 2019	BUY	$17.72 - $22.51 $545,279 - $692,677	30,772 New	30,772 $612,000
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.6 $263,603 - $353,152	-18,018 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.23 - $20.35 $310,450 - $366,666	18,018 New	18,018 $338,000

Others Institutions Holding AMPH

# of Institutions

286

Shares Held

34.9M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.88B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Amphastar Pharmaceuticals, Inc. Transaction History